Diabetic foot syndrome that affects patients under regular haemodialysis is a complex mechanism mainly based on patient metabolism, neurosensitive abnormalities, and plantar pressure dysfunctions. \n In this work, we study the clinical and biological profile of the diabetic foot in 43 Tunisian diabetic patients under regular haemodialysis.\n The majority of the patients have type 2 diabetes. All had diabetic nephropathy and several comorbidities, 57% secondary hyperparathyroidism, 35% had a normalized proteins catabolic rate, and 44.1% had hypoalbuminemia. Fifty one percent of the patients have feet deformities; among them respectively 44.1%, 25.6% and 34.8% have toes claws, hallux valgus and a history of ulceration or amputation.\nThirteen patients had diabetic neuropathy and 53.48% had sensory neuropathy. Neuropathic pain was found in 18.6% of patients.\n Regarding factors related to haemodialysis, the impact of “nutritional, inflammatory, anemic and disorders of the metabolism of calcium and of phosphorus” factors was clear. Diabetes inherent factors such as, duration of evolution, balance, and the tendency to obesity represent others complicating risk factors for our patients. Also, Systolic Pressure Index, which constitutes another risk factor, was greatly increased. Similarly, sensory and autonomic neuropathies were strongly present, as well as bone deformities. All these different factors are well known for their primordial impact on foot ulcers development.